Vivesto AB (FRA:OMA) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OMA Vivesto AB FRA:OMA
39 GF Score
Price €0.77
! 1 Warning Sign
View Full Analysis

What is Vivesto AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:OMA
39GF Score
Vivesto AB FRA:OMA
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivesto AB Business Description

Other Exchanges VIVE:Sweden
Address Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
39GF Score

Get the complete analysis for FRA:OMA

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price